SynOx Therapeutics Ltd
Founded 2020 · 33 employees on LinkedIn · 1 known investors
SynOx Therapeutics develops treatments for people with tenosynovial giant cell tumours (TGCT) and other macrophage-mediated diseases. It is a biopharmaceutical company focused on addressing unmet clinical needs in these conditions.
Investors · 1
Frequently asked questions
- What does SynOx Therapeutics Ltd do?
- SynOx Therapeutics develops treatments for people with tenosynovial giant cell tumours (TGCT) and other macrophage-mediated diseases. It is a biopharmaceutical company focused on addressing unmet clinical needs in these conditions.
- Who are SynOx Therapeutics Ltd's investors?
- SynOx Therapeutics Ltd's investors include HealthCap.